secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2024-08-05T23:59:59+00:00
Accession:  0001822479-24-000038
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health Q2 net revenue up 8.3% to $277M; adj. EBITDA up 6.9% to $137M
---------------------------------------------------------------------------

- Net income $9M ($0.03 diluted) vs $24M ($0.08) in Q2 2023; decline due to debt refinancing charges.
- Adjusted EPS $0.19 vs $0.20; higher interest expense weighed on earnings.
- Refinanced debt structure, extending maturities to 2031; reaffirmed 2024 outlook.
- First-half 2024 revenue $525M (+10.3%), adj. EBITDA $249M (+9.8%), adj. EPS $0.32.
- All three segments (Sterigenics, Nordion, Nelson Labs) reported volume increases in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247924000038/0001822479-24-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247924000038/shc-20240805.htm
  HTML page:      https://secwatch.observer/filing/0001822479-24-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer